PAA
TNDM icon

Peregrine Asset Advisers’s Tandem Diabetes Care TNDM Stock Holding History

Peregrine Asset Advisers’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-63,420
Closed -$2.41M – 110
2018
Q4 		$2.41M Buy
+63,420
New +$2.24M 3.14% 10

Other funds holding TNDM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Peregrine Asset Advisers's TNDM Position: Q1 2019 in Review

Peregrine Asset Advisers sold out of Tandem Diabetes Care (TNDM) in Q1 2019, closing a stake of 63,420 shares — an estimated $2.41M sold.

Peregrine Asset Advisers first reported a position in TNDM in Q4 2018 and held it in 1 quarter. The position peaked at $2.41M in Q4 2018. 265 funds tracked by Wall St. Rank hold TNDM as of Q1 2019.

  • Peregrine Asset Advisers reported no remaining Tandem Diabetes Care position as of Q1 2019 after selling out during the quarter.
  • Peregrine Asset Advisers sold 63,420 Tandem Diabetes Care shares in Q1 2019, an estimated $2.41M.
  • Peregrine Asset Advisers first reported a position in Tandem Diabetes Care in Q4 2018 and held it in 1 quarter.
  • Peregrine Asset Advisers's Tandem Diabetes Care position peaked at $2.41M in Q4 2018.
  • 265 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2019.

Based on Peregrine Asset Advisers's 13F filing for Q1 2019, filed 29 Apr 2019.